A hierarchical classifier based on human blood plasma fluorescence for non-invasive colorectal cancer screening.

Authors:
Felipe Soares
Felipe Soares
Institute of Informatics - Universidade Federal do Rio Grande do Sul
Brazil
Karin Becker
Karin Becker
University of North Dakota
Grand Forks | United States
Michel J Anzanello
Michel J Anzanello
Federal University of Rio Grande do Sul
Brazil

Artif Intell Med 2017 Oct 20;82:1-10. Epub 2017 Sep 20.

Department of Industrial Engineering - Universidade Federal do Rio Grande do Sul, Av. Osvaldo Aranha, 99-5° andar, Porto Alegre, RS, Brazil. Electronic address:

Colorectal cancer (CRC) a leading cause of death by cancer, and screening programs for its early identification are at the heart of the increasing survival rates. To motivate population participation, non-invasive, accurate, scalable and cost-effective diagnosis methods are required. Blood fluorescence spectroscopy provides rich information that can be used for cancer identification. The main challenges in analyzing blood fluorescence data for CRC classification are related to its high dimensionality and inherent variability, especially when analyzing a small number of samples. In this paper, we present a hierarchical classification method based on plasma fluorescence to identify not only CRC, but also adenomas and other non-malignant colorectal findings that may require further medical investigation. A feature selection algorithm is proposed to deal with the high dimensionality and select discriminant fluorescence wavelengths. These are used to train a binary support vector machine (SVM) in the first level to identify the CRC samples. The remaining samples are then presented to a one-class SVM trained on healthy subjects to detect deviant samples, and thus non-malignant findings. This hierarchical design, together with the one class-SVM, aims to reduce the effects of small samples and high variability. Using a dataset analyzed in previous studies comprised of 12,341 wavelengths, we achieved much superior results. Sensitivity and specificity are 0.87 and 0.95 for CRC detection, and 0.60 and 0.79 for non-malignant findings, respectively. Compared to related work, the proposed method presented a better accuracy, required fewer features, and provides a unified approach that expands CRC detection to non-malignant findings.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.artmed.2017.09.004DOI Listing
October 2017
4 Reads

Publication Analysis

Top Keywords

non-malignant findings
12
high dimensionality
8
plasma fluorescence
8
colorectal cancer
8
identify crc
8
cancer screening
8
crc detection
8
blood fluorescence
8
crc
6
samples
5
fluorescence
5
vector machine
4
healthy subjects
4
machine svm
4
binary support
4
fluorescence wavelengths
4
wavelengths train
4
train binary
4
svm level
4
support vector
4

Similar Publications

DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.

Int J Cancer 2012 Sep 19;131(5):1153-7. Epub 2011 Nov 19.

Department of Surgical Sciences, Minimally Invasive Surgery Research Center, University of Insubria, Varese, Italy.

Colorectal cancer (CRC) screening rates are currently suboptimal. Blood-based screening could improve rates of earlier detection for CRC and adenomatous colorectal polyps. In this study, we evaluated the feasibility of plasma-based detection of early CRC and adenomatous polyps using array-mediated analysis methylation profiling of 56 genes implicated in carcinogenesis. Read More

View Article
September 2012

Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.

Gastroenterology 2017 10 15;153(4):980-987. Epub 2017 Jun 15.

ATGen Canada Inc, Laval, QC, Canada.

Background & Aims: Low activity of natural killer (NK) cells has been associated with increased risk of cancer and has been reported in patients with colorectal cancer (CRC). Activity of NK cells can be measured in a small volume of whole blood by a commercially available test. We investigated whether this test could be used to identify patients with CRC, using findings from colonoscopy as a reference standard. Read More

View Article
October 2017

Serrated lesions and hyperplastic (serrated) polyposis relationship with colorectal cancer: classification and surveillance recommendations.

Authors:
Janina Orlowska

Gastrointest Endosc 2013 Jun;77(6):858-71

Pathology Department, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.

View Article
June 2013

CA11-19: a tumor marker for the detection of colorectal cancer.

Gastrointest Endosc 2016 Mar 28;83(3):545-51. Epub 2015 Aug 28.

MD Anderson (retired), Houston, Texas, USA.

Background And Aim: Colorectal cancer (CRC) remains the second most frequent cause of cancer deaths in the United States. Blood tests using tumor-related antigens aid in diagnosing CRC. However, higher sensitivity and specificity are needed before an acceptable tumor antigen blood test for CRC is clinically useful. Read More

View Article
March 2016